MedElevator Войти в исследования
← Поиск публикаций

DOI 10.11406/rinketsu.63.550

Медицинская библиотека · [Rinsho ketsueki] The Japanese journal of clinical hematology · 2022

[Extensive reduction of anti-human leukocyte antigen antibodies after chemotherapy including blinatumomab for B-cell acute lymphoblastic leukemia].

Nishida Aya, Mitsuki Takashi, Ishiwata Kazuya, Wake Atsushi

Клинический случайСтатьяПеревод в очереди

Аннотация

A 66-year-old man with fever was diagnosed with B-cell acute lymphoblastic leukemia. He failed to achieve complete remission after initial hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD) therapy and was referred to our hospital to undergo allogeneic stem cell transplantation. Bone marrow aspiration showed 97.5% lymphoblasts positive for CD19. Blood tests revealed the presence of broad antihuman leukocyte antigen (HLA) antibodies. After blinatumomab therapy, bone marrow aspiration showed 19.6% blasts. Furthermore, after additional mini-mitoxantrone, etoposide, and cytarabine (mini MEC) therapy, the patient achieved complete remission. Interestingly, after blinatumomab therapy, the blood tests revealed that the titers of anti-HLA antibodies had decreased, and cord blood transplantation was performed in complete remission. This case report revealed that chemotherapy including blinatumomab, which targets CD19-positive cells, has the potential to decrease antibody-producing cells, thus leading to a dramatic reduction of anti-HLA antibodies.

Для цитирования: Nishida Aya, Mitsuki Takashi, Ishiwata Kazuya, Wake Atsushi. [Extensive reduction of anti-human leukocyte antigen antibodies after chemotherapy including blinatumomab for B-cell acute lymphoblastic leukemia].. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2022. DOI: 10.11406/rinketsu.63.550.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.